# Quality Assessment Form: Risk of Bias and Study Quality

**Study ID**: [Auto-generated]
**Reviewer**: [Name]
**Assessment Date**: [Date]
**Second Reviewer**: [Name]
**Verification Date**: [Date]

## 1. Study Design Classification

**Primary Design**:
- [ ] Randomized Controlled Trial (RCT)
- [ ] Cluster-Randomized Controlled Trial (Cluster-RCT)
- [ ] Interrupted Time Series (ITS)
- [ ] Controlled Before-After (CBA)
- [ ] Other: ____________________________

**Assessment Tool**:
- RCTs/Cluster-RCTs: → Cochrane Risk of Bias 2.0
- ITS/CBA: → EPOC Quality Criteria
- Other designs: → ROBINS-I

## 2. Risk of Bias Assessment for RCTs/Cluster-RCTs (RoB 2.0)

### 2.1 Bias arising from the randomization process

**Allocation Sequence Random**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Allocation Concealment**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Baseline Imbalance**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Overall Risk**:
- [ ] Low
- [ ] Some concerns
- [ ] High

### 2.2 Bias due to deviations from intended interventions

**Blinding of Participants**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Blinding of Personnel**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Protocol Deviations**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Overall Risk**:
- [ ] Low
- [ ] Some concerns
- [ ] High

### 2.3 Bias due to missing outcome data

**Missing Data**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Balance in Missing Data**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Appropriate Analysis**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Overall Risk**:
- [ ] Low
- [ ] Some concerns
- [ ] High

### 2.4 Bias in measurement of the outcome

**Blinding of Outcome Assessors**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Subjective Outcomes**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Detection Bias**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Overall Risk**:
- [ ] Low
- [ ] Some concerns
- [ ] High

### 2.5 Bias in selection of the reported result

**Protocol Available**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Reported Results Match Protocol**:
- [ ] Yes
- [ ] Probably yes
- [ ] No information
- [ ] Probably no
- [ ] No

**Overall Risk**:
- [ ] Low
- [ ] Some concerns
- [ ] High

### 2.6 Overall Risk of Bias

**Overall Judgment**:
- [ ] Low risk of bias
- [ ] Some concerns
- [ ] High risk of bias

## 3. Quality Assessment for ITS Studies (EPOC Criteria)

### 3.1 Protection against secular changes

**Intervention independent of other changes**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

**Appropriate analysis**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

### 3.2 Protection against detection bias

**Blinded outcome assessment**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

**Reliable outcome measurement**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

### 3.3 Completeness of outcome data

**All data reported**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

**Reasons for missing data reported**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

### 3.4 Protection against selection bias (if relevant)

**Predefined inclusion criteria**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

**Predefined exclusion criteria**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

### 3.5 Appropriate analysis

**ARIMA or similar method**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

**Justification for number of points**:
- [ ] Done
- [ ] Not clear
- [ ] Not done

**Overall ITS Quality**:
- [ ] Low risk of bias
- [ ] Moderate risk of bias
- [ ] High risk of bias

## 4. Additional Quality Indicators

### 4.1 Sample Size and Power

**Sample Size Calculation**:
- [ ] Reported and adequate
- [ ] Reported but inadequate
- [ ] Not reported

**Power Analysis**:
- [ ] Adequate (≥80%)
- [ ] Inadequate (<80%)
- [ ] Not reported

### 4.2 Statistical Methods

**Appropriate for Study Design**:
- [ ] Yes
- [ ] Unclear
- [ ] No

**Appropriate for Outcome Type**:
- [ ] Yes
- [ ] Unclear
- [ ] No

**Clustering Adjustment** (for cluster designs):
- [ ] Yes
- [ ] No
- [ ] N/A

### 4.3 Confounding Control

**Baseline Characteristics**:
- [ ] Balanced between groups
- [ ] Adjusted in analysis
- [ ] Imbalanced

**Time-varying Confounders**:
- [ ] Controlled
- [ ] Not controlled
- [ ] N/A

**Secular Trends**:
- [ ] Controlled
- [ ] Not controlled
- [ ] N/A

### 4.4 Generalizability

**Setting Representativeness**:
- [ ] High (typical hospitals)
- [ ] Moderate
- [ ] Low (specialized centers)

**Population Representativeness**:
- [ ] High (typical patients)
- [ ] Moderate
- [ ] Low (selected patients)

## 5. Publication and Reporting Quality

### 5.1 Protocol Registration

**PROSPERO or ClinicalTrials.gov**:
- [ ] Registered
- [ ] Not registered
- [ ] Registration number: ____________________________

### 5.2 CONSORT/STROBE Compliance

**Reporting Guideline Followed**:
- [ ] Yes
- [ ] Partially
- [ ] No

**Flow Diagram**:
- [ ] Included
- [ ] Not included

### 5.3 Funding and Conflicts

**Funding Source Disclosed**:
- [ ] Yes
- [ ] No

**Conflicts of Interest**:
- [ ] Declared (none)
- [ ] Declared (present)
- [ ] Not declared

## 6. Study Limitations (as reported by authors)

**Acknowledged Limitations**:
____________________________________________________________
____________________________________________________________
____________________________________________________________

**Unacknowledged Limitations** (reviewer assessment):
____________________________________________________________
____________________________________________________________
____________________________________________________________

## 7. Overall Quality Rating

**GRADE Approach**:
- [ ] High quality
- [ ] Moderate quality
- [ ] Low quality
- [ ] Very low quality

**Rationale for Rating**:
____________________________________________________________
____________________________________________________________

## 8. Reviewer Notes

**Quality Assessment Challenges**:
____________________________________________________________
____________________________________________________________

**Additional Concerns**:
____________________________________________________________
____________________________________________________________

**Second Reviewer Agreement**:
- [ ] Complete agreement
- [ ] Minor discrepancies
- [ ] Major discrepancies
- Discrepancies resolved: [ ] Yes [ ] No

---

**Quality Assessment Verification**:
- [ ] All domains assessed
- [ ] Judgments justified
- [ ] Second reviewer verification completed
- [ ] Discrepancies resolved
